These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5092912)

  • 1. [Animal experiments on the effects of a hyperosmolar solution of xantinol-nicotinate on large intestine motility in obstructive ileus].
    Willmen HR; Ziatarski G; Lynen FK; Langer S; Heinze H
    Med Welt; 1971 Sep; 22(36):1378-81. PubMed ID: 5092912
    [No Abstract]   [Full Text] [Related]  

  • 2. [The influence of xanthinol nicotinate and of a hyperosmolar solution on the motility of the colon].
    Willmen HR; Kogel H
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):133-8. PubMed ID: 1254378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on the human fibrinolytic system of prolonged intravenous infusion of high doses of Complamin (xantinol nicotinate).
    Bouvier CA; Berthoud S
    Helv Med Acta; 1968 Mar; 34(2):170-86. PubMed ID: 4232105
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of respiratory distress syndrome in prematures with xantinol nicotinate].
    Kellner R; Reich J
    Z Kinderheilkd; 1972; 113(1):19-32. PubMed ID: 4560318
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical studies on the effectiveness of Xantinol-nicotinate in chronic hepatitis and liver cirrhosis].
    Dohrmann RE; Konrad D; Sawade H; Kühl I
    Med Klin; 1968 Nov; 63(44):1772-6. PubMed ID: 5704508
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinogen turnover during the treatment with xantinol nicotinate.
    Cultrera G; Giarola P; Gibelli A; Baldoni E; Cuttin S; Galetti G; Serenth'a P
    Arzneimittelforschung; 1971 Jul; 21(7):954-7. PubMed ID: 5109508
    [No Abstract]   [Full Text] [Related]  

  • 7. [Animal experiments on ileus of the large intestine with special reference to large bowel motility].
    Zlatarski G; Willmen HR; Lynen FK; Langer S; Heinze H; Karhoff B; Schweizer K
    Z Gastroenterol; 1972; 10(2):114-26. PubMed ID: 4671724
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nicotinic acid blood levels after application of xanthinolnicotinate in a new galenic retard preparation].
    Brenner G
    Arzneimittelforschung; 1975 Feb; 25(2):237-40. PubMed ID: 1173039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of hyperosmolar solutions on mesenteric blood flow and in postoperative intestinal atonia].
    Messmer K; Schmidt-Mende M
    Anaesthesist; 1971 May; 20(5):184-9. PubMed ID: 5089585
    [No Abstract]   [Full Text] [Related]  

  • 10. [The influence of xantinol nicotinate on vascularisation and formation of vascular collaterals in extremity arteries in the animal experiment].
    Schmitt G; Daake H
    Arzneimittelforschung; 1971 Apr; 21(4):446-9. PubMed ID: 5108138
    [No Abstract]   [Full Text] [Related]  

  • 11. [Research on the fibrinolytic effects developed in vivo from 7-(2-[pyrid(3)yl-methylamino]ethyl) theophylline nicotinate. Preliminary note].
    Preliminare N
    Clin Ter; 1974 Nov; 71(4):321-33. PubMed ID: 4459005
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood circulation increase in various organs following xantinol-nicotinate treatment in the acute animal experiment].
    Winter R; Schmitt G; Knoche H
    Arzneimittelforschung; 1973 May; 23(5):652-3. PubMed ID: 4740205
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of xantinol nicotinate on blood sugar level and free fatty acids in rats].
    Brenner G
    Arzneimittelforschung; 1971 Aug; 21(8):1179-83. PubMed ID: 5110015
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of therapy and adjustment of diabetics with xanthine nicotinate].
    Hahn J; Kaffarnik H
    Med Klin; 1969 May; 64(22):1042-5. PubMed ID: 5800195
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modification of the vascular changes of the ocular fundus by xantinol nicotinate].
    von Grósz I; Födö V
    Med Welt; 1969 Aug; 35():1916-7. PubMed ID: 5809867
    [No Abstract]   [Full Text] [Related]  

  • 16. [Kinin liberation by xantinol nicotinate?].
    Seidel G; Wentz U
    Arzneimittelforschung; 1972 Jun; 22(6):1012-3. PubMed ID: 5068347
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of Xantinol nicotinate (Complamina) in experimental pulmonary fibrin embolism.
    Boruah KD; Chakravarti RN; Wahi PL
    Indian J Med Res; 1974 Jun; 62(6):923-9. PubMed ID: 4435907
    [No Abstract]   [Full Text] [Related]  

  • 18. Intestinal nitric oxide synthase activity changes during experimental colon obstruction.
    Palásthy Z; Kaszaki J; Lázár G; Nagy S; Boros M
    Scand J Gastroenterol; 2006 Aug; 41(8):910-8. PubMed ID: 16803689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a nicotinic acid derivative on the radiation induced mitosis inhibition of Ehrlic ascites tumor cells].
    Kaufmann H; Piaszek L; Tiemann W; Bartholomä HJ
    Arzneimittelforschung; 1968 Dec; 18(12):1579-82. PubMed ID: 5756256
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in serum electrolytes, serum proteins and substances, normally contained in the urine during therapy of feto-placentar insufficiency using xantinol nicotinate and heparin].
    Kidess E; Bieling C; Kunz S; Liebich HM
    Med Welt; 1973 Dec; 24(51):2029-32. PubMed ID: 4774572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.